Literature DB >> 8240550

Gastroduodenal ulceration associated with flunixin meglumine administration in three dogs .

M A Vonderhaar1, S K Salisbury.   

Abstract

In 3 clinically ill dogs, signs of gastroduodenal ulceration were first noticed within 7 days of beginning flunixin meglumine administration and included pyrexia, anorexia, weight loss, vomiting, melena, pain on abdominal palpation, and abdominal distention. One dog was euthanatized and 2 dogs recovered after surgical repair of the perforated ulcers and treatment of peritonitis. Prolonged administration of flunixin meglumine should be avoided, especially in debilitated dogs or when concurrently administering other nonsteroidal anti-inflammatory drugs or corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240550

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

Review 1.  Nonsteroidal anti-inflammatory analgesics in pain management in dogs and cats.

Authors:  K A Mathews
Journal:  Can Vet J       Date:  1996-09       Impact factor: 1.008

2.  A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs.

Authors:  K A Mathews; D M Paley; R A Foster; A E Valliant; S S Young
Journal:  Can Vet J       Date:  1996-09       Impact factor: 1.008

Review 3.  Emesis in dogs: a review.

Authors:  C Elwood; P Devauchelle; J Elliott; V Freiche; A J German; M Gualtieri; E Hall; E den Hertog; R Neiger; D Peeters; X Roura; K Savary-Bataille
Journal:  J Small Anim Pract       Date:  2010-01       Impact factor: 1.522

4.  Prevalence of gastrointestinal lesions in dogs chronically treated with nonsteroidal anti-inflammatory drugs.

Authors:  Kasey Mabry; Tracy Hill; Mary Katherine Tolbert
Journal:  J Vet Intern Med       Date:  2021-02-03       Impact factor: 3.333

5.  Pharmacological evaluation of NSAID-induced gastropathy as a "Translatable" model of referred visceral hypersensitivity.

Authors:  Michele Hummel; Terri Knappenberger; Meghan Reilly; Garth T Whiteside
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.